Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

BiVictriX Therapeutics PLC

BVX
Current price
10 GBX 0 GBX (0.00%)
Last closed 8.5 GBX
ISIN GB00BNXH3K91
Sector Healthcare
Industry Biotechnology
Exchange London Exchange
Capitalization 8 259 687 GBX
Yield for 12 month -16.67 %
1Y
3Y
5Y
10Y
15Y
BVX
21.11.2021 - 28.11.2021

BiVictriX Therapeutics plc, a biotechnology company, engages in the research and experimental development of pharmaceutical products in the United Kingdom. The company develops Bi-Cygni, a proprietary platform that combines the discovery of novel, cancer-selective twin-antigen pairs or fingerprints with bispecific antibody engineering insights to create anti-cancer therapeutics. Its lead program is BVX001, a first-in-class Bi Cygni antibody drug conjugates to treat acute myeloid leukemia. The company also develops BVX002 for treating ovarian and other solid tumors; and BVX003 for bladder and other solid tumors. The company was formerly known as BiVictriX plc and changed its name to BiVictriX Therapeutics plc in August 2021. BiVictriX Therapeutics plc was founded in 2016 and is headquartered in Macclesfield, the United Kingdom. Address: Mereside, Macclesfield, United Kingdom, SK10 4TG

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

5 099 GBX

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-16 514 198 GBX

Last Year

-15 112 977 GBX

Current Quarter

-9 007 773 GBX

Last Quarter

-8 907 647 GBX

Key Figures BVX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -3 172 738 GBX
Operating Margin TTM
PE Ratio
Return On Assets TTM -62.99 %
PEG Ratio
Return On Equity TTM -103.99 %
Wall Street Target Price 5 099 GBX
Revenue TTM
Book Value 0.028 GBX
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM -521 448 GBX
Earnings per share -0.04 GBX
Diluted Eps TTM -0.04 GBX
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics BVX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History BVX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation BVX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -2.4546
Price Book MRQ 3.5803

Financials BVX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BVX

For 52 weeks

7.01 GBX 14.01 GBX
50 Day MA 10.92 GBX
Shares Short Prior Month
200 Day MA 10.74 GBX
Short Ratio
Shares Short
Short Percent